Kardiyovasküler Sistem ve Endokrinoloji

Yıl 2005, Cilt: 3 Sayı: 1, 33 - 36, 01.06.2005

Ömer Tarım

Öz

Ondokuzuncu yüzyılda Graves ve Addison hastalıklarının tanımlanması ile kardiyoloji ve endokrinoloji ilişkisi daha iyi anlaşılmaya başlanmış, atrial natriüretik hormonun keşfi ise kalbi endokrin organlar sınıfına sokmuştur 1 .

Kaynakça

• 1. Klee GG. Biochemical thyroid function testing. Mayo Clin Proc 1994;69:469-74.
• 2. Aono J, Nobuoka S, Nagashima J, et al. Heart failure in three patients with acromegaly: echocardiographic assessment. Intern Med 1998;37:599-603.
• 3. Ezzat S, Forster MJ, Berchtold P, et al. Acromegaly. Clinical and biochemical features in 500 patients. Medicine 1994;73:233-40.
• 4. Minniti G, Moroni C, Jaffrain-Rea ML, et al. Prevalance of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring. Clin Endocrinol 1998;48:149-52. 5. Strauch G, Vallotton MB, Touitou Y. The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly. N Engl J Med 1972;287:795-9.
• 6. Özbey N, Öncül A, Bu¤ra Z, et al. Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage. J Endocrinol Invest 1997;20:305-11.
• 7. Baldelli R, Ferretti E, Jaffrain-Rea ML, et al. Cardiac effects of slowrelease lanreotide, a slow-release somatostatin analog, in acromegalic patients. J Clin Endocrinol Metab 1999;84:527-32.
• 8. Lombardi G, Colao A, Ferone D, et al. Effect of growth hormone cardiac function. Horm Res 1997;48:38-42.
• 9. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993;87:1435-41.
• 10. Hammond HK, White FC, Buxton IL, et al. Increased myocardial beta receptors and adrenergic responses in hyperthyroid pigs. Am J Physiol 1987;252:283-90.
• 11. Davis PJ, Davis FB. Acute cellular actions of thyroid hormone and myocardial function. Ann Thorac Surg 1993;56(Suppl 1):16-23.
• 12. Channick BJ, Adlin EV, Marks AD, et al. Hyperthyroidism and mitral valve prolapse. N Engl J Med 1981;305:497-500.
• 13. von Olshaasen K, Bischoff S, Kahaly G, et al. Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 1989;63:930-3.
• 14. Nakazawa HK, Sakurai K, Hamada N, et al. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 1982;72:903-6.
• 15. Shenoy MM, Goldman JM. Hypothyroid cardiomyopathy: echocardiographic documentation of reversibility. Am J Med Sci 1987;294:1-9.
• 16. Surawicz B, Manigiardi ML. Electrocardiogram in endocrine and metabolic disorders. In: Rios JC, ed. Clinical electrocardiographic correlation. Philadelphia: FA Davis Co, 1977:243-8.
• 17. Goldman J, Matz R, Mortimer R, Freeman R. High elevation of creatin phosphokinase in hypothyroidism. An isoenzyme analysis. JAMA 1977;283:325-6.
• 18. Ladenson PW, Goldenheim PD, Cooper DS, et al. Early peripheral responses to intravenous L-thyroxine in primary hypothyroidism. Am J Med 1982; 73:467- 74.
• 19. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
• 20. Newman CM, Price A, Davies DW, et al. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998;79:121-7.
• 21. Stefenelli T, Mayr H, Bergler-Klein J, et al. Primary hyperthyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993;95:197-202.
• 22. Roberts WC, Waller BF. Effect of chronic hypercalcemia on the heart: an analysis of 18 necropsy patients. Am J Med 1981;71: 371-84.
• 23. Suzuki T, Ikeda U, Fujikawa H, et al. Hypocalcemic heart failure: a reversible form of heart muscle disease. Clin Cardiol 1998; 21:227-8.
• 24. Kelly JJ, Mangos G, Williamson PM, Whitworth JA. Cortisol and hypertension. Clin Exp Pharmacol Physiol 1998; 25 (Suppl): S51-6.
• 25. Krakoff L, Nicolis G, Amsel B. Pathogenesis of hypertension in Cushing’s syndrome. Am J Med 1975; 58:216-20.
• 26. Pessina AC, Sacchetto A, Rossi GP. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension. Adv Exp Med Biol 1997; 432:63-9.
• 27. Rossi GP, Sacchetto A, Pavan E, et al. Remodeling of the left ventricle in primary aldosteronism due to Conn’s adenoma. Circulation 1997; 95:1471-8.
• 28. Sun Y, Ramires FJ, Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997; 35:138-47.
• 29. McManus BM, Fleury TA, Roberts WC. Fatal catecholamine crisis in pheochromocytoma: curable form of cardiac arrest. Am Heart J 1981;102:930-2.
• 30. Mosca L, Manson JE, Sutherland SE, et al. Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 1997; 96:2468-82